In synovial cells of rheumatoid arthritis (RA) patients, a high-glucose environment sustains NF-κB pathway activation via glycolysis-dependent H3K4me3 modifications, promoting secretion of IL-6 and TNF-α 86. The gene discussed is IL6; the disease is rheumatoid arthritis.